Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China · Delayed Price · Currency is CNY 24.96
+0.85 (3.53%)
Jul 31, 2026, 3:04 PM CST
SHE:300255 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 187.32 | 128 | 236.44 | 230.92 | 797.8 | 543.21 |
Cash & Short-Term Investments | 187.32 | 128 | 236.44 | 230.92 | 797.8 | 543.21 |
Cash Growth | -33.29% | -45.86% | 2.39% | -71.06% | 46.87% | 12.93% |
Accounts Receivable | 306.27 | 251.19 | 265.74 | 238.08 | 452.99 | 317.09 |
Other Receivables | 13.76 | 58.36 | 42.55 | 80.43 | 43.03 | 39.24 |
Receivables | 320.02 | 309.55 | 308.29 | 318.52 | 496.02 | 356.33 |
Inventory | 1,181 | 1,232 | 1,386 | 1,644 | 2,431 | 2,285 |
Prepaid Expenses | - | 0.09 | 0.08 | - | 0.02 | 0.29 |
Other Current Assets | 90 | 42.22 | 71.86 | 82.14 | 172.24 | 223.68 |
Total Current Assets | 1,778 | 1,712 | 2,002 | 2,276 | 3,898 | 3,408 |
Property, Plant & Equipment | 1,803 | 1,790 | 1,713 | 1,591 | 1,483 | 1,193 |
Long-Term Investments | - | - | - | - | 1.46 | 5.8 |
Goodwill | - | - | - | - | 1.78 | 3.56 |
Other Intangible Assets | 311.05 | 313.57 | 308.13 | 320.55 | 263.82 | 274.06 |
Long-Term Deferred Tax Assets | 17.6 | 19.43 | 21.89 | 20.97 | 11.78 | 14 |
Long-Term Deferred Charges | 502.37 | 493.62 | 432.58 | 361.03 | 286.26 | 219.84 |
Other Long-Term Assets | 26.66 | 22.31 | 44.32 | 26.65 | 89.82 | 71.56 |
Total Assets | 4,439 | 4,351 | 4,523 | 4,596 | 6,036 | 5,190 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 399.64 | 434.64 | 307.47 | 263.38 | 249.81 | 106.49 |
Accrued Expenses | 23.49 | 29.42 | 28.17 | 37.46 | 54.25 | 36.57 |
Short-Term Debt | 1,557 | 1,318 | 887.55 | 967.22 | 1,010 | 1,272 |
Current Portion of Long-Term Debt | 343.33 | 540.13 | 873.18 | 586.14 | 351.6 | 134.22 |
Current Portion of Leases | - | 80.28 | 56.88 | 0.39 | - | - |
Current Income Taxes Payable | 6.07 | 0.89 | 2.36 | 1.14 | 3.45 | 23.62 |
Current Unearned Revenue | 9.36 | 9.82 | 14.53 | 20.8 | 47.45 | 65.86 |
Other Current Liabilities | 57.72 | 70.81 | 32.65 | 44.4 | 71.65 | 95.31 |
Total Current Liabilities | 2,396 | 2,484 | 2,203 | 1,921 | 1,788 | 1,734 |
Long-Term Debt | 775.93 | 584.32 | 659.47 | 811.76 | 1,129 | 332.47 |
Long-Term Leases | 22.71 | 42.25 | 64.44 | 1.26 | - | - |
Long-Term Unearned Revenue | 66.28 | 66.73 | 60.01 | 62.48 | 64.8 | 51.02 |
Long-Term Deferred Tax Liabilities | 0.25 | 0.26 | 0.31 | 0.35 | 0.19 | 0.2 |
Other Long-Term Liabilities | 5.27 | 5.27 | - | - | - | - |
Total Liabilities | 3,267 | 3,183 | 2,987 | 2,797 | 2,982 | 2,118 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 919.06 | 919.06 | 919.06 | 919.06 | 934.97 | 934.97 |
Additional Paid-In Capital | 422.74 | 422.74 | 422.74 | 422.74 | 526.84 | 526.84 |
Retained Earnings | -131.51 | -137.38 | 220.52 | 469.99 | 1,794 | 1,800 |
Treasury Stock | - | - | - | - | -120.01 | -120.01 |
Comprehensive Income & Other | -0.14 | -0.27 | -0.05 | -0.13 | -77.86 | -73.5 |
Total Common Equity | 1,210 | 1,204 | 1,562 | 1,812 | 3,058 | 3,069 |
Minority Interest | -38.58 | -36.08 | -26.52 | -11.97 | -4.02 | 3.34 |
Shareholders' Equity | 1,172 | 1,168 | 1,536 | 1,800 | 3,054 | 3,072 |
Total Liabilities & Equity | 4,439 | 4,351 | 4,523 | 4,596 | 6,036 | 5,190 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 2,699 | 2,565 | 2,542 | 2,367 | 2,490 | 1,739 |
Net Cash (Debt) | -2,512 | -2,437 | -2,305 | -2,136 | -1,692 | -1,195 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -2.74 | -2.66 | -2.49 | -2.32 | -1.93 | -1.28 |
Filing Date Shares Outstanding | 919.06 | 919.06 | 919.06 | 919.06 | 919.06 | 919.06 |
Total Common Shares Outstanding | 919.06 | 919.06 | 919.06 | 919.06 | 919.06 | 919.06 |
Working Capital | -618.56 | -772.01 | -200.38 | 354.94 | 2,110 | 1,674 |
Book Value Per Share | 1.32 | 1.31 | 1.70 | 1.97 | 3.33 | 3.34 |
Tangible Book Value | 899.1 | 890.57 | 1,254 | 1,491 | 2,792 | 2,791 |
Tangible Book Value Per Share | 0.98 | 0.97 | 1.36 | 1.62 | 3.04 | 3.04 |
Buildings | - | 936.24 | 932.88 | 915.66 | 808.9 | 701.24 |
Machinery | - | 538.89 | 538.71 | 545.8 | 389.26 | 339.53 |
Construction In Progress | - | 839.2 | 708.97 | 547.74 | 642.27 | 462.72 |